🇺🇸 FDA
Patent

US 11974992

Use of serotonin 5-HT1A receptor agonists to treat diseases associated with sudden unexpected death in epilepsy

granted A61KA61K31/404A61K31/4427

Quick answer

US patent 11974992 (Use of serotonin 5-HT1A receptor agonists to treat diseases associated with sudden unexpected death in epilepsy) held by The Regents of the University of California expires Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue May 07 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 02 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/404, A61K31/4427, A61K31/445, A61K31/451